EPZ020411

CAS No. 1700663-41-7

EPZ020411 ( EPZ-020411 )

Catalog No. M12596 CAS No. 1700663-41-7

EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 212 In Stock
10MG 353 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EPZ020411
  • Note
    Research use only, not for human use.
  • Brief Description
    EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM.
  • Description
    EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM, displays 10-fold and 20-fold selectivity over PRMT1/8, and >100-fold over other histone methyltransferases (PRMT3/4/5/7); dose-dependently decreases H3R2 methylation A375 cell line with IC50 of 0.637 uM, with no affect levels of PRMT6 expression; exhibits good bioavailability following subcutaneous dosing in rats making it a suitable tool for potential in vivo target validation studies.
  • Synonyms
    EPZ-020411
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    PRMT6
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    1700663-41-7
  • Formula Weight
    442.59
  • Molecular Formula
    C25H38N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CNCCN(C)CC1=C(NN=C1)C2=CC=C(C=C2)OC3CC(C3)OCCC4CCOCC4
  • Chemical Name
    1,2-Ethanediamine, N1,N2-dimethyl-N1-[[3-[4-[[trans-3-[2-(tetrahydro-2H-pyran-4-yl)ethoxy]cyclobutyl]oxy]phenyl]-1H-pyrazol-4-yl]methyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mitchell LH, et al. ACS Med Chem Lett. 2015 Apr 6;6(6):655-9.
molnova catalog
related products
  • WDR5 WIN site inhibi...

    WDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM.

  • GSK-2807

    GSK-2807 (GSK 2807, GSK2807) is a potent and selective, SAM-competitive inhibitor of SMYD3 with Ki of 14 nM.

  • WDR5-MLL1 inhibitor

    WDR5-MLL1 inhibitor is a novel potent inhibitor of WDR5-MLL1 interaction, binds to WDR5 with Kd of 1 nM.